Notable Analyst Upgrades and Downgrades for Week of September 23, 2019



Upgrades:



Kimberly Clark (NYSE:KMB) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued to clients and investors on Monday, The Fly reports.

KMB has been the topic of several other reports. Zacks Investment Research raised Kimberly Clark from a “hold” rating to a “buy” rating and set a $149.00 target price on the stock in a report on Thursday, August 22nd. Bank of America reissued a “neutral” rating and set a $143.00 target price (up from $135.00) on shares of Kimberly Clark in a report on Wednesday, June 19th. ValuEngine lowered Kimberly Clark from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Wells Fargo & Co reissued a “hold” rating and set a $130.00 target price on shares of Kimberly Clark in a report on Tuesday, July 23rd. Finally, Morgan Stanley increased their target price on Kimberly Clark from $145.00 to $147.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 24th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $131.36. Read more …

Guggenheim upgraded shares of Sanofi (NYSE:SNY) from a neutral rating to a buy rating in a research note issued to investors on Monday, BenzingaRatingsTable reports.

Several other equities analysts also recently weighed in on the company. Jefferies Financial Group reiterated a buy rating on shares of Sanofi in a research report on Thursday, August 29th. Sanford C. Bernstein initiated coverage on Sanofi in a research report on Tuesday, September 3rd. They set an outperform rating and a $52.00 target price on the stock. UBS Group upgraded Sanofi from a neutral rating to a buy rating in a research report on Wednesday, August 14th. JPMorgan Chase & Co. restated a neutral rating on shares of Sanofi in a report on Tuesday, August 6th. Finally, Zacks Investment Research upgraded Sanofi from a hold rating to a buy rating and set a $47.00 price objective on the stock in a report on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Sanofi currently has a consensus rating of Buy and an average target price of $49.67. Read more …

Jefferies Financial Group upgraded shares of Apple (NASDAQ:AAPL) from a hold rating to a buy rating in a research report report published on Tuesday morning, The Fly reports. Jefferies Financial Group currently has $260.00 price objective on the iPhone maker’s stock, up from their prior price objective of $210.00.

Several other brokerages also recently commented on AAPL. Longbow Research reiterated a hold rating on shares of Apple in a research note on Tuesday, September 10th. Raymond James upgraded Apple from a market perform rating to an outperform rating and set a $250.00 price target on the stock in a research note on Thursday, July 18th. Goldman Sachs Group dropped their price target on Apple from $187.00 to $165.00 and set a neutral rating on the stock in a research note on Friday, September 13th. Monness Crespi & Hardt restated a buy rating and issued a $265.00 price target (up from $245.00) on shares of Apple in a research note on Wednesday, July 31st. Finally, Needham & Company LLC raised their price target on Apple from $225.00 to $250.00 and gave the stock a strong-buy rating in a research note on Wednesday, September 11th. Four research analysts have rated the stock with a sell rating, seventeen have given a hold rating, twenty-four have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of $219.47. Read more …


Bank of America upgraded shares of Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) from a neutral rating to a buy rating in a research note published on Tuesday, BenzingaRatingsTable reports. The brokerage currently has $62.00 price target on the bank’s stock, up from their previous price target of $52.00.

Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Bank of Nova Scotia from a buy rating to a hold rating in a research note on Thursday, August 29th. ValuEngine cut shares of Bank of Nova Scotia from a hold rating to a sell rating in a research note on Tuesday, July 2nd. Barclays reaffirmed an average rating and issued a $78.00 price objective on shares of Bank of Nova Scotia in a research note on Thursday, May 30th. BMO Capital Markets cut their price objective on shares of Bank of Nova Scotia from $80.00 to $78.00 and set an outperform rating for the company in a research note on Wednesday, August 28th. Finally, Canaccord Genuity reaffirmed a hold rating on shares of Bank of Nova Scotia in a research note on Wednesday, August 28th. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of $74.14. Read more …


AbbVie (NYSE:ABBV) was upgraded by research analysts at Citigroup from a “neutral” rating to a “buy” rating in a report issued on Thursday, The Fly reports.


ABBV has been the topic of a number of other reports. Wolfe Research upgraded shares of AbbVie from an “underperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Leerink Swann upgraded shares of AbbVie to a “buy” rating in a research report on Tuesday, July 2nd. Piper Jaffray Companies raised their price target on shares of AbbVie from $80.00 to $81.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 4th. ValuEngine cut shares of AbbVie from a “sell” rating to a “strong sell” rating in a report on Wednesday, June 26th. Finally, Svb Leerink raised shares of AbbVie from a “market perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a report on Wednesday, June 26th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $91.20. Read more …

Cenovus Energy (NYSE:CVE) (TSE:CVE) was upgraded by equities research analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a report released on Thursday, The Fly reports.

Separately, CIBC upgraded Cenovus Energy from a “neutral” rating to an “outperform” rating in a report on Thursday, July 18th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $13.41. Shares of NYSE CVE opened at $9.72 on Thursday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.54 and a current ratio of 1.02. The business’s 50 day moving average price is $8.92 and its 200-day moving average price is $8.98. Cenovus Energy has a fifty-two week low of $6.15 and a fifty-two week high of $10.82. The company has a market cap of $12.13 billion, a price-to-earnings ratio of -5.59, a PEG ratio of 3.36 and a beta of 0.96. Read more …

Texas Instruments (NASDAQ:TXN) was upgraded by research analysts at Bank of America from a “neutral” rating to a “buy” rating in a note issued to investors on Friday, The Fly reports.

Other analysts also recently issued reports about the company. JPMorgan Chase & Co. raised their target price on Texas Instruments from $130.00 to $138.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. Jefferies Financial Group raised their target price on Texas Instruments from $137.00 to $170.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Loop Capital raised their target price on Texas Instruments to $140.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. SunTrust Banks raised their target price on Texas Instruments to $133.00 and gave the company a “hold” rating in a research note on Wednesday, July 24th. Finally, BidaskClub upgraded Texas Instruments from a “sell” rating to a “hold” rating in a research note on Saturday, June 1st. Two investment analysts have rated the stock with a sell rating, seventeen have issued a hold rating and thirteen have given a buy rating to the company. Texas Instruments currently has a consensus rating of “Hold” and an average target price of $118.71. Read more …


Downgrades:



Clorox (NYSE:CLX) was downgraded by equities research analysts at Barclays from an “equal weight” rating to an “underweight” rating in a report released on Monday, The Fly reports.

A number of other brokerages have also recently commented on CLX. UBS Group raised their target price on Clorox from $110.00 to $128.00 and gave the stock a “sell” rating in a report on Friday, August 2nd. Royal Bank of Canada raised their target price on Clorox to $161.00 and gave the stock a “sector perform” rating in a report on Friday, August 2nd. Wells Fargo & Co reaffirmed a “hold” rating and issued a $153.00 target price on shares of Clorox in a report on Thursday, August 1st. Morgan Stanley raised their target price on Clorox from $141.00 to $144.00 and gave the stock an “underweight” rating in a report on Friday, August 2nd. Finally, Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a report on Monday, July 29th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the stock. Clorox has a consensus rating of “Hold” and an average target price of $154.31. Read more …


Simon Property Group (NYSE:SPG) was downgraded by stock analysts at Citigroup from a “buy” rating to a “neutral” rating in a research report issued on Monday, The Fly reports.

A number of other research analysts also recently issued reports on the stock. ValuEngine downgraded shares of Simon Property Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 2nd. SunTrust Banks dropped their target price on shares of Simon Property Group from $185.00 to $160.00 and set a “hold” rating on the stock in a research report on Friday, August 23rd. JPMorgan Chase & Co. dropped their target price on shares of Simon Property Group from $198.00 to $193.00 and set an “overweight” rating on the stock in a research report on Monday, June 3rd. Deutsche Bank dropped their target price on shares of Simon Property Group from $191.00 to $188.00 and set a “hold” rating on the stock in a research report on Tuesday, June 11th. Finally, Morgan Stanley dropped their target price on shares of Simon Property Group from $170.00 to $157.00 and set an “equal weight” rating on the stock in a research report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $186.58. Read more …

NESTLE S A/S (OTCMKTS:NSRGY) was downgraded by equities researchers at Royal Bank of Canada from a “sector perform” rating to an “underperform” rating in a research report issued on Wednesday, The Fly reports.


A number of other analysts also recently weighed in on the company. Deutsche Bank downgraded NESTLE S A/S from a “buy” rating to a “hold” rating in a research report on Monday, September 9th. HSBC initiated coverage on NESTLE S A/S in a research report on Thursday, June 27th. They set a “hold” rating for the company. Finally, Zacks Investment Research upgraded NESTLE S A/S from a “hold” rating to a “buy” rating and set a $116.00 target price for the company in a research report on Friday, July 5th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $108.00. Read more …

Comments